olmesartan has been researched along with Angioneurotic Edema in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, R; Hamamoto, T; Minami, C; Yamada, H | 1 |
| Bi, X; Shan, L; Wang, S; Zhou, Y | 1 |
| Enriquez, A; Fernandez, C; Jaramillo, JC; Mielgo, R; Vasquez, JL | 1 |
3 other study(ies) available for olmesartan and Angioneurotic Edema
| Article | Year |
|---|---|
[Orolingual Angioedema after Recombinant Tissue Plasminogen Activator Treatment in Acute Cardiogenic Cerebral Embolism Patient Using Olmesartan: A Case Report].
Topics: Acute Disease; Aged, 80 and over; Angioedema; Angiotensin II Type 1 Receptor Blockers; Cerebral Infarction; Humans; Imidazoles; Intracranial Embolism; Male; Recombinant Proteins; Tetrazoles; Tissue Plasminogen Activator | 2022 |
Orolingual angioedema associated with olmesartan use after recombinant tissue plasminogen activator treatment of acute stroke.
Topics: Acute Disease; Aged, 80 and over; Angioedema; Antihypertensive Agents; Female; Humans; Imidazoles; Lip; Methylprednisolone; Recombinant Proteins; Stroke; Tetrazoles; Tissue Plasminogen Activator; Tongue; Uvula | 2014 |
Severe angioedema associated with olmesartan.
Topics: Adrenal Cortex Hormones; Aged; Angioedema; Angiotensin II Type 1 Receptor Blockers; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Hypertension; Imidazoles; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2011 |